Search research articles
Contact Us
Filters
Showing results (11-20 of 283) with videos related to
Page
of 29
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 10, 2000
Rational design of viral vectors based on rigorous analysis of capsid structures
D T Curiel
Chest
|
June 1, 1997
Conference summary. Gene-based therapies for inherited and acquired disorders of the lung
D T Curiel
Gene Therapy
|
September 26, 2001
CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors
R Alemany, D T Curiel
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
|
October 16, 2001
[Viral therapy of cancer]
K Suzuki, D T Curiel
Gene Therapy
|
July 1, 1996
Towards the use of replicative adenoviral vectors for cancer gene therapy
R Miller, D T Curiel
Nature Biotechnology
|
May 21, 1998
Viral vectors show promise in Colorado
P N Reynolds, D T Curiel
Human Gene Therapy
|
January 20, 1997
A phase I study of recombinant adenovirus vector-mediated delivery of an anti-erbB-2 single-chain (sFv) antibody gene for previously treated ovarian and extraovarian cancer patients
R D Alvarez, D T Curiel
Advanced Drug Delivery Reviews
|
December 4, 2001
Conditional gene targeting for cancer gene therapy
Y S Haviv, D T Curiel
Cancer Gene Therapy
|
March 3, 2001
Towards the optimal vector for prostate cancer gene therapy; a caPCURE meeting report
M G Rots, D T Curiel
The Lancet. Oncology
|
March 22, 2002
Conditionally replicative adenoviral vectors for cancer gene therapy
J Gómez-Navarro, D T Curiel
Page
of 29
Search research articles
Search
Showing results (11-20 of 283) with videos related to
Sort By:
Page
of 29
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 10, 2000
Rational design of viral vectors based on rigorous analysis of capsid structures
D T Curiel
Chest
|
June 1, 1997
Conference summary. Gene-based therapies for inherited and acquired disorders of the lung
D T Curiel
Gene Therapy
|
September 26, 2001
CAR-binding ablation does not change biodistribution and toxicity of adenoviral vectors
R Alemany, D T Curiel
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion
|
October 16, 2001
[Viral therapy of cancer]
K Suzuki, D T Curiel
Gene Therapy
|
July 1, 1996
Towards the use of replicative adenoviral vectors for cancer gene therapy
R Miller, D T Curiel
Nature Biotechnology
|
May 21, 1998
Viral vectors show promise in Colorado
P N Reynolds, D T Curiel
Human Gene Therapy
|
January 20, 1997
A phase I study of recombinant adenovirus vector-mediated delivery of an anti-erbB-2 single-chain (sFv) antibody gene for previously treated ovarian and extraovarian cancer patients
R D Alvarez, D T Curiel
Advanced Drug Delivery Reviews
|
December 4, 2001
Conditional gene targeting for cancer gene therapy
Y S Haviv, D T Curiel
Cancer Gene Therapy
|
March 3, 2001
Towards the optimal vector for prostate cancer gene therapy; a caPCURE meeting report
M G Rots, D T Curiel
The Lancet. Oncology
|
March 22, 2002
Conditionally replicative adenoviral vectors for cancer gene therapy
J Gómez-Navarro, D T Curiel
Page
of 29